| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 123.65B | 133.15B | 121.24B | 108.54B | 104.78B | 91.86B |
| Gross Profit | 17.14B | 18.47B | 16.93B | 15.47B | 13.79B | 11.45B |
| EBITDA | 5.18B | 5.59B | 5.54B | 5.57B | 4.71B | 3.95B |
| Net Income | 2.63B | 3.65B | 2.97B | 2.95B | 2.91B | 2.25B |
Balance Sheet | ||||||
| Total Assets | 63.51B | 78.82B | 74.16B | 66.06B | 64.11B | 56.64B |
| Cash, Cash Equivalents and Short-Term Investments | 6.61B | 8.19B | 10.26B | 7.90B | 8.43B | 8.17B |
| Total Debt | 16.52B | 18.22B | 15.22B | 12.51B | 14.63B | 11.95B |
| Total Liabilities | 33.85B | 45.38B | 43.46B | 37.86B | 38.11B | 32.85B |
| Stockholders Equity | 28.88B | 32.86B | 29.89B | 27.41B | 25.23B | 23.04B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -3.85B | -32.90M | 3.13B | -1.54B | -1.07B |
| Operating Cash Flow | 0.00 | -3.62B | 251.24M | 3.60B | -96.77M | -539.21M |
| Investing Cash Flow | 0.00 | -119.65M | 309.92M | -764.62M | -1.24B | -280.79M |
| Financing Cash Flow | 0.00 | 1.59B | 1.51B | -3.54B | 1.45B | 1.47B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥106.85B | 9.51 | ― | 2.85% | 1.06% | -7.68% | |
76 Outperform | ¥14.51B | 8.19 | ― | 3.03% | 6.36% | 41.53% | |
73 Outperform | ¥28.93B | 7.48 | ― | 3.96% | 9.83% | 23.69% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
57 Neutral | ¥36.46B | 9.56 | ― | 3.90% | 53.30% | 35.91% | |
57 Neutral | ¥32.84B | 8.50 | ― | 4.66% | -8.90% | 9.92% |